ATHLETES FOOT SPRAY

ATHLETES FOOT SPRAY was reported 1352 times

ATHLETES FOOT SPRAY is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HYPOXANTHINE-GUANINE PHOSPHORIBOSYL TRANSFERASE DEFICIENCY 1 0.3333
1 ELEPHANTIASIS NOSTRAS VERRUCOSA 1 0.1250
2 ANTI-HLA ANTIBODY TEST POSITIVE 1 0.0588
3 HEPATITIS SYPHILITIC 1 0.0556
4 HUMAN T-CELL LYMPHOTROPIC VIRUS INFECTION 1 0.0417
5 VULVOVAGINAL BURNING SENSATION 242 0.0396
6 CHEMICAL BURN OF GENITALIA 4 0.0328
7 CONJUNCTIVOCHALASIS 1 0.0323
8 INSTILLATION SITE HAEMORRHAGE 1 0.0256
9 BEREAVEMENT 1 0.0217
10 MIXED HYPERLIPIDAEMIA 1 0.0192
11 FUNGAL RHINITIS 2 0.0187
12 VULVOVAGINAL PAIN 79 0.0164
13 VULVOVAGINAL PRURITUS 73 0.0144
14 DISRUPTIVE MOOD DYSREGULATION DISORDER 1 0.0135
15 KAWASAKI'S DISEASE 1 0.0132
16 AORTIC VALVE DISEASE MIXED 1 0.0123
17 PERIPHERAL NERVE LESION 4 0.0121
18 ACUTE MONOCYTIC LEUKAEMIA 2 0.0110
19 VULVOVAGINAL DISCOMFORT 47 0.0106
20 LOBULAR BREAST CARCINOMA IN SITU 1 0.0105
21 ELECTROCONVULSIVE THERAPY 1 0.0092
22 ALLERGY TO IMMUNOGLOBULIN THERAPY 1 0.0092
23 CATHETER THROMBOSIS 1 0.0089
24 VAGINAL MUCOSAL BLISTERING 2 0.0089
25 MELANOSIS COLI 1 0.0086
26 TINEA VERSICOLOUR 3 0.0083
27 MESOTHELIOMA MALIGNANT 3 0.0081
28 CAR T-CELL-RELATED ENCEPHALOPATHY SYNDROME 1 0.0081
29 BURKHOLDERIA TEST POSITIVE 1 0.0081
30 INTENTIONAL PRODUCT MISUSE TO CHILD 1 0.0078
31 PAROTID GLAND ENLARGEMENT 5 0.0077
32 INTRAUTERINE INFECTION 1 0.0074
33 VULVOVAGINAL ERYTHEMA 6 0.0072
34 NEURAL TUBE DEFECT 5 0.0069
35 CLEFT LIP 6 0.0069
36 VULVOVAGINAL RASH 3 0.0068
37 VULVOVAGINAL SWELLING 12 0.0066
38 LIPOSUCTION 1 0.0065
39 KIDNEY CONGESTION 1 0.0065
40 CALCULUS URETHRAL 1 0.0065
41 CREATININE URINE DECREASED 1 0.0063
42 CONFUSIONAL AROUSAL 1 0.0062
43 HAND-EYE COORDINATION IMPAIRED 1 0.0059
44 INTESTINAL HAEMATOMA 1 0.0057
45 JEJUNOSTOMY 1 0.0055
46 APPLICATION SITE INJURY 1 0.0053
47 VULVOVAGINAL INJURY 3 0.0053
48 EPIDURAL INJECTION 1 0.0051
49 GASTROSTOMY TUBE SITE COMPLICATION 1 0.0050
50 MERALGIA PARAESTHETICA 1 0.0047
51 DEAFNESS TRANSITORY 4 0.0047
52 CYTOMEGALOVIRUS TEST POSITIVE 8 0.0045
53 INFUSION SITE PHLEBITIS 1 0.0044
54 VULVOVAGINAL INFLAMMATION 2 0.0043
55 FALSE NEGATIVE INVESTIGATION RESULT 3 0.0043
56 CORNEAL NEOVASCULARISATION 1 0.0040
57 TINEA CRURIS 2 0.0040
58 HYDRONEPHROSIS 30 0.0040
59 SUPRAPUBIC PAIN 2 0.0039
60 ANAL ATRESIA 2 0.0037
61 STOMA SITE IRRITATION 2 0.0037
62 MORAXELLA INFECTION 1 0.0036
63 COLON CANCER RECURRENT 1 0.0036
64 GENITAL BLISTER 1 0.0036
65 GENITAL PARAESTHESIA 1 0.0034
66 FALLOPIAN TUBE DISORDER 1 0.0034
67 AURICULAR SWELLING 2 0.0033
68 ALLERGY TO VACCINE 1 0.0032
69 CENTRAL SEROUS CHORIORETINOPATHY 2 0.0029
70 CONJUNCTIVITIS BACTERIAL 1 0.0029
71 TONGUE BITING 6 0.0029
72 GENITAL SWELLING 2 0.0029
73 THERAPEUTIC PROCEDURE 4 0.0029
74 MENTAL RETARDATION 1 0.0028
75 CYTOMEGALOVIRUS ENTERITIS 1 0.0028
76 VIRAL HAEMORRHAGIC CYSTITIS 2 0.0028
77 CRYPTORCHISM 3 0.0027
78 CERVICAL POLYP 1 0.0026
79 HYDROURETER 1 0.0026
80 IMPAIRED REASONING 1 0.0026
81 BACTERIAL VAGINOSIS 4 0.0026
82 HUMAN PAPILLOMA VIRUS TEST POSITIVE 1 0.0025
83 CHEMICAL INJURY 2 0.0024
84 FOETAL DISORDER 2 0.0024
85 CORNEAL DYSTROPHY 1 0.0024
86 CONGENITAL CARDIOVASCULAR ANOMALY 2 0.0024
87 ONYCHOMADESIS 10 0.0024
88 MESOTHELIOMA 3 0.0023
89 GENITAL BURNING SENSATION 2 0.0023
90 MOUTH BREATHING 1 0.0023
91 DIVORCED 1 0.0023
92 ANAEMIA MEGALOBLASTIC 1 0.0022
93 GASTRIC FISTULA 1 0.0022
94 FEEDING INTOLERANCE 1 0.0022
95 MATERNAL DRUGS AFFECTING FOETUS 17 0.0022
96 CIRRHOSIS ALCOHOLIC 1 0.0022
97 VAGINAL DISCHARGE 22 0.0022
98 ANAPHYLACTOID SHOCK 1 0.0021
99 HYPERMETROPIA 2 0.0021
100 GASTROSCHISIS 1 0.0021
101 APLASIA 4 0.0020
102 ABORTION THREATENED 1 0.0020
103 KAPOSI'S SARCOMA 1 0.0020
104 EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) 1 0.0020
105 GLARE 1 0.0019
106 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
107 MARITAL PROBLEM 1 0.0019
108 BURSITIS INFECTIVE 1 0.0018
109 INTERTRIGO 1 0.0018
110 MACULE 5 0.0018
111 BODY TINEA 1 0.0018
112 EXPOSURE TO CHEMICAL POLLUTION 3 0.0018
113 BACTERIURIA 1 0.0018
114 CHEMICAL BURN 2 0.0017
115 CORNEAL EPITHELIUM DEFECT 1 0.0017
116 CAMPYLOBACTER GASTROENTERITIS 1 0.0017
117 AORTIC VALVE STENOSIS 3 0.0017
118 APPLICATION SITE DISCOMFORT 3 0.0017
119 INCORRECT DRUG DOSAGE FORM ADMINISTERED 1 0.0016
120 FEBRILE CONVULSION 2 0.0016
121 STOMA SITE ERYTHEMA 3 0.0016
122 BACILLUS INFECTION 1 0.0016
123 CANCER PAIN 4 0.0016
124 ENTEROCOCCUS TEST POSITIVE 1 0.0015
125 COMPULSIONS 1 0.0015
126 COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS 1 0.0015
127 ANGULAR CHEILITIS 1 0.0014
128 INTERNATIONAL NORMALISED RATIO INCREASED 41 0.0014
129 DERMATITIS DIAPER 1 0.0014
130 CONGENITAL HYDRONEPHROSIS 1 0.0014
131 CYTOMEGALOVIRUS INFECTION 23 0.0014
132 ACCOMMODATION DISORDER 1 0.0014
133 BLUNTED AFFECT 1 0.0014
134 GENITAL PAIN 2 0.0014
135 HEART SOUNDS ABNORMAL 1 0.0013
136 SECONDARY ADRENOCORTICAL INSUFFICIENCY 2 0.0013
137 ENTEROVESICAL FISTULA 1 0.0013
138 ELECTROCARDIOGRAM PR PROLONGATION 1 0.0013
139 CYTOMEGALOVIRUS ENTEROCOLITIS 1 0.0013
140 BREAST FEEDING 1 0.0013
141 ELECTROCARDIOGRAM QT CORRECTED INTERVAL PROLONGED 1 0.0013
142 FUNGAEMIA 2 0.0013
143 VULVOVAGINAL MYCOTIC INFECTION 5 0.0013
144 BREAST CALCIFICATIONS 1 0.0013
145 ENDOMETRIAL HYPERPLASIA 1 0.0012
146 BREAST OPERATION 1 0.0012
147 GRANULOMA SKIN 1 0.0012
148 BALANOPOSTHITIS 1 0.0012
149 PATHOLOGICAL GAMBLING 2 0.0012
150 ODYNOPHAGIA 7 0.0012
151 CRANIOSYNOSTOSIS 1 0.0012
152 DERMATITIS ACNEIFORM 7 0.0011
153 PARTIAL SEIZURES 6 0.0011
154 INFUSION SITE DISCOLOURATION 1 0.0011
155 ANOGENITAL WARTS 1 0.0011
156 CATHETER MANAGEMENT 1 0.0011
157 INTESTINAL INFARCTION 1 0.0011
158 STOMA SITE DISCHARGE 3 0.0011
159 CERUMEN IMPACTION 1 0.0011
160 LOBAR PNEUMONIA 2 0.0011
161 HYPERACUSIS 4 0.0011
162 RENAL TUBULAR DISORDER 3 0.0011
163 MICROANGIOPATHY 1 0.0011
164 BLADDER CATHETERISATION 1 0.0010
165 CROSS SENSITIVITY REACTION 1 0.0010
166 LYMPHADENECTOMY 1 0.0010
167 BONE MARROW DEPRESSION 1 0.0010
168 HAEMOPHILUS INFECTION 1 0.0010
169 PYELONEPHRITIS ACUTE 2 0.0010
170 COLON ADENOMA 1 0.0010
171 ERYSIPELAS 5 0.0010
172 BRAIN STEM INFARCTION 1 0.0010
173 ANAPHYLACTOID REACTION 4 0.0010
174 CAROTID ARTERIOSCLEROSIS 1 0.0010
175 VAGINAL HAEMORRHAGE 42 0.0010
176 INFUSION SITE DISCOMFORT 1 0.0010
177 HYPOSPADIAS 2 0.0010
178 FEEDING DISORDER NEONATAL 1 0.0010
179 GALLBLADDER ENLARGEMENT 1 0.0009
180 INFUSION SITE MASS 1 0.0009
181 DRUG EXPOSURE VIA BREAST MILK 1 0.0009
182 BLOOD TESTOSTERONE ABNORMAL 1 0.0009
183 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 1 0.0009
184 CARDIAC HYPERTROPHY 1 0.0009
185 FACIAL PAIN 8 0.0009
186 LYMPHOCYTE COUNT ABNORMAL 1 0.0009
187 EYE MOVEMENT DISORDER 6 0.0009
188 GASTROINTESTINAL BACTERIAL INFECTION 1 0.0009
189 ADMINISTRATION SITE PAIN 1 0.0009
190 APPLICATION SITE PAIN 19 0.0009
191 RALES 5 0.0009
192 SPINAL COLUMN STENOSIS 4 0.0008
193 INGROWING NAIL 2 0.0008
194 HAEMORRHAGE SUBCUTANEOUS 3 0.0008
195 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 1 0.0008
196 DYSFUNCTIONAL UTERINE BLEEDING 1 0.0008
197 RETROPERITONEAL HAEMORRHAGE 2 0.0008
198 FREEZING PHENOMENON 3 0.0008
199 INJECTION SITE ABSCESS 2 0.0008
200 ALLERGY TO CHEMICALS 1 0.0008
201 INTRADUCTAL PROLIFERATIVE BREAST LESION 1 0.0008
202 LIP DISCOLOURATION 1 0.0008
203 EXCORIATION 2 0.0008
204 RESPIRATORY RATE INCREASED 7 0.0008
205 BRONCHIAL SECRETION RETENTION 1 0.0008
206 LEFT ATRIAL DILATATION 1 0.0008
207 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 1 0.0008
208 MICROCEPHALY 1 0.0008
209 LIP DRY 7 0.0008
210 ADJUSTMENT DISORDER 1 0.0008
211 COUNTERFEIT PRODUCT ADMINISTERED 1 0.0008
212 GASTROENTERITIS NOROVIRUS 1 0.0008
213 OESOPHAGEAL CANDIDIASIS 3 0.0008
214 CORNEAL OPACITY 1 0.0007
215 BLOOD PHOSPHORUS INCREASED 2 0.0007
216 APPLICATION SITE HAEMORRHAGE 2 0.0007
217 SUBDURAL HAEMORRHAGE 2 0.0007
218 INFUSION SITE RASH 1 0.0007
219 CULTURE URINE POSITIVE 1 0.0007
220 ANTIPSYCHOTIC DRUG LEVEL INCREASED 2 0.0007
221 GLOMERULAR FILTRATION RATE ABNORMAL 1 0.0007
222 GENITAL RASH 1 0.0007
223 SALIVARY HYPERSECRETION 7 0.0007
224 INVESTIGATION ABNORMAL 1 0.0007
225 CARDIAC MURMUR 6 0.0007
226 TOOTH ABSCESS 7 0.0007
227 SPINAL OSTEOARTHRITIS 6 0.0007
228 GENERALISED ANXIETY DISORDER 1 0.0007
229 GROWTH RETARDATION 2 0.0007
230 APRAXIA 1 0.0007
231 INTERCEPTED DRUG DISPENSING ERROR 1 0.0007
232 INFERTILITY 1 0.0007
233 EPICONDYLITIS 1 0.0007
234 GENITAL HERPES 1 0.0007
235 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
236 CUSHINGOID 2 0.0006
237 BLOOD CALCIUM DECREASED 7 0.0006
238 DISINHIBITION 1 0.0006
239 SKIN EROSION 2 0.0006
240 DENTAL IMPLANTATION 1 0.0006
241 TOOTH INFECTION 8 0.0006
242 EXPIRED DRUG ADMINISTERED 3 0.0006
243 NEAR DEATH EXPERIENCE 2 0.0006
244 ORGANISING PNEUMONIA 3 0.0006
245 ILLUSION 1 0.0006
246 SKIN INJURY 2 0.0006
247 HEPATORENAL SYNDROME 1 0.0006
248 AMMONIA INCREASED 3 0.0006
249 ECCHYMOSIS 4 0.0006
250 MILIARIA 1 0.0006
251 APLASIA PURE RED CELL 2 0.0006
252 ORAL DISCOMFORT 8 0.0006
253 MENINGITIS CRYPTOCOCCAL 1 0.0006
254 PRODUCT CONTAMINATION 2 0.0006
255 BLOOD CREATININE INCREASED 36 0.0006
256 BODY TEMPERATURE ABNORMAL 1 0.0005
257 BLINDNESS TRANSIENT 4 0.0005
258 ON AND OFF PHENOMENON 3 0.0005
259 FEELING DRUNK 4 0.0005
260 BLADDER SPASM 1 0.0005
261 IMPULSIVE BEHAVIOUR 2 0.0005
262 HYPOPROTEINAEMIA 1 0.0005
263 FACE INJURY 2 0.0005
264 PRODUCT PACKAGING ISSUE 5 0.0005
265 INTENTIONAL MISUSE 1 0.0005
266 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
267 LYMPHADENOPATHY MEDIASTINAL 1 0.0005
268 SKIN ATROPHY 3 0.0005
269 CUTANEOUS LUPUS ERYTHEMATOSUS 1 0.0005
270 PELVIC FRACTURE 4 0.0005
271 SKIN FISSURES 10 0.0005
272 COLOSTOMY 1 0.0005
273 CANDIDIASIS 2 0.0005
274 OBSESSIVE-COMPULSIVE DISORDER 4 0.0005
275 FUNGAL SKIN INFECTION 2 0.0005
276 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 3 0.0005
277 APPLICATION SITE PRURITUS 11 0.0005
278 ATRIAL THROMBOSIS 1 0.0005
279 TOOTH LOSS 10 0.0005
280 ANAL PRURITUS 1 0.0005
281 ACCIDENTAL EXPOSURE 2 0.0005
282 HEPATIC NEOPLASM MALIGNANT 1 0.0005
283 SKIN HAEMORRHAGE 7 0.0005
284 FEBRILE BONE MARROW APLASIA 2 0.0005
285 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 8 0.0005
286 APPLICATION SITE SCAB 1 0.0005
287 INFUSION SITE BRUISING 1 0.0005
288 INCORRECT PRODUCT ADMINISTRATION DURATION 10 0.0005
289 BIPOLAR I DISORDER 1 0.0005
290 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
291 DEVICE RELATED INFECTION 7 0.0005
292 GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0005
293 ELECTROCARDIOGRAM T WAVE INVERSION 1 0.0005
294 RHINITIS ALLERGIC 2 0.0004
295 BASAL CELL CARCINOMA 7 0.0004
296 SUSPECTED OFF LABEL USE 2 0.0004
297 THERAPEUTIC PRODUCT EFFECT DELAYED 2 0.0004
298 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
299 INFUSION SITE INFECTION 1 0.0004
300 MOUTH ULCERATION 9 0.0004
301 VAGINAL INFECTION 2 0.0004
302 TONGUE DISORDER 3 0.0004
303 CANDIDA INFECTION 7 0.0004
304 LYMPHADENITIS 1 0.0004
305 APPLICATION SITE BURN 2 0.0004
306 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
307 HYPERNATRAEMIA 2 0.0004
308 CATHETER SITE HAEMORRHAGE 1 0.0004
309 BRAIN ABSCESS 1 0.0004
310 CHEMICAL BURN OF SKIN 1 0.0004
311 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 2 0.0004
312 DIABETIC COMPLICATION 1 0.0004
313 PHARYNGEAL OEDEMA 6 0.0004
314 MEAN CELL VOLUME INCREASED 1 0.0004
315 APNOEA 3 0.0004
316 PULMONARY HAEMORRHAGE 3 0.0004
317 AGRANULOCYTOSIS 7 0.0004
318 ANGIONEUROTIC OEDEMA 1 0.0004
319 HYPERLACTACIDAEMIA 1 0.0004
320 BREAST CANCER METASTATIC 4 0.0004
321 GAMBLING DISORDER 1 0.0004
322 ABDOMINAL RIGIDITY 1 0.0004
323 SEPSIS 41 0.0004
324 HYDROCEPHALUS 2 0.0004
325 DRUG INTERACTION 58 0.0004
326 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
327 HEART RATE ABNORMAL 2 0.0004
328 PRODUCT LEAKAGE 2 0.0004
329 ACUTE PULMONARY OEDEMA 2 0.0004
330 PAIN IN JAW 10 0.0004
331 LIP PAIN 1 0.0003
332 HERPES VIRUS INFECTION 2 0.0003
333 FIBULA FRACTURE 1 0.0003
334 ADENOVIRUS INFECTION 1 0.0003
335 LUMBAR SPINAL STENOSIS 1 0.0003
336 URINE ODOUR ABNORMAL 2 0.0003
337 CATARACT OPERATION 2 0.0003
338 MUSCLE RIGIDITY 4 0.0003
339 BLOOD CULTURE POSITIVE 1 0.0003
340 HIV INFECTION 1 0.0003
341 LOSS OF EMPLOYMENT 1 0.0003
342 FOETAL GROWTH RESTRICTION 2 0.0003
343 KERATITIS 1 0.0003
344 DYSCHEZIA 1 0.0003
345 DIABETIC FOOT 1 0.0003
346 UROSEPSIS 3 0.0003
347 DIASTOLIC DYSFUNCTION 1 0.0003
348 ANKLE FRACTURE 5 0.0003
349 BLOOD ALKALINE PHOSPHATASE INCREASED 8 0.0003
350 APPLICATION SITE IRRITATION 4 0.0003
351 INCORRECT DRUG ADMINISTRATION DURATION 9 0.0003
352 INFUSION SITE PRURITUS 1 0.0003
353 GAMMA-GLUTAMYLTRANSFERASE INCREASED 7 0.0003
354 SLEEP APNOEA SYNDROME 6 0.0003
355 BURNING SENSATION 22 0.0003
356 WHITE BLOOD CELL COUNT ABNORMAL 2 0.0003
357 GLOSSODYNIA 7 0.0003
358 CHOLESTASIS 6 0.0003
359 ROTATOR CUFF SYNDROME 4 0.0003
360 LOOSE TOOTH 1 0.0003
361 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0003
362 BACTERIAL SEPSIS 1 0.0003
363 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
364 POLYP 2 0.0003
365 ANHEDONIA 8 0.0003
366 INFUSION SITE HAEMORRHAGE 1 0.0003
367 CYTOLYTIC HEPATITIS 1 0.0003
368 DYSURIA 11 0.0003
369 POST-TRAUMATIC STRESS DISORDER 2 0.0003
370 TOXIC SKIN ERUPTION 3 0.0003
371 B-CELL LYMPHOMA 1 0.0003
372 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
373 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
374 BLOOD CREATININE ABNORMAL 1 0.0003
375 MICTURITION DISORDER 1 0.0003
376 UNDERDOSE 21 0.0003
377 PETECHIAE 3 0.0003
378 PRODUCT ODOUR ABNORMAL 3 0.0003
379 DERMATITIS 6 0.0003
380 CARPAL TUNNEL SYNDROME 4 0.0003
381 RIGHT VENTRICULAR FAILURE 2 0.0003
382 SCRATCH 3 0.0003
383 HEART DISEASE CONGENITAL 1 0.0003
384 THERMAL BURN 2 0.0003
385 GLOSSITIS 1 0.0003
386 FIBRIN D DIMER INCREASED 1 0.0003
387 HAEMORRHAGIC DIATHESIS 1 0.0003
388 CONJUNCTIVAL HYPERAEMIA 1 0.0003
389 MONOCYTE COUNT INCREASED 1 0.0003
390 BLOOD PHOSPHORUS DECREASED 1 0.0003
391 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 8 0.0003
392 STAPHYLOCOCCAL INFECTION 9 0.0003
393 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 5 0.0003
394 MOUTH HAEMORRHAGE 2 0.0003
395 SENSITIVE SKIN 2 0.0003
396 HAEMATOMA 7 0.0003
397 ARTHROPOD BITE 2 0.0003
398 JOINT STIFFNESS 7 0.0003
399 MATERNAL EXPOSURE TIMING UNSPECIFIED 1 0.0003
400 STATUS EPILEPTICUS 3 0.0003
401 OSTEOPENIA 4 0.0003
402 DERMATITIS CONTACT 3 0.0003
403 INCREASED APPETITE 5 0.0003
404 BOWEL MOVEMENT IRREGULARITY 2 0.0003
405 CARDIOPULMONARY FAILURE 1 0.0003
406 CEREBRAL ATROPHY 1 0.0003
407 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
408 ASPHYXIA 2 0.0002
409 HYPERURICAEMIA 1 0.0002
410 FUNGAL INFECTION 8 0.0002
411 ABDOMINAL PAIN LOWER 6 0.0002
412 CONDITION AGGRAVATED 72 0.0002
413 HEPATIC CYTOLYSIS 3 0.0002
414 HAEMATURIA 8 0.0002
415 PYELONEPHRITIS 2 0.0002
416 SKIN SWELLING 2 0.0002
417 CHAPPED LIPS 1 0.0002
418 ORTHOSTATIC HYPOTENSION 4 0.0002
419 IMMOBILE 1 0.0002
420 MELANOCYTIC NAEVUS 1 0.0002
421 ASPARTATE AMINOTRANSFERASE INCREASED 12 0.0002
422 STEVENS-JOHNSON SYNDROME 5 0.0002
423 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
424 IMPAIRED GASTRIC EMPTYING 3 0.0002
425 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
426 LUMBAR VERTEBRAL FRACTURE 1 0.0002
427 IRON DEFICIENCY ANAEMIA 2 0.0002
428 LOCALISED OEDEMA 1 0.0002
429 FLANK PAIN 2 0.0002
430 ALANINE AMINOTRANSFERASE INCREASED 13 0.0002
431 BLOOD URINE PRESENT 4 0.0002
432 HYPERSENSITIVITY 39 0.0002
433 FEELING JITTERY 4 0.0002
434 GESTATIONAL DIABETES 1 0.0002
435 GASTROINTESTINAL TOXICITY 1 0.0002
436 HUMERUS FRACTURE 1 0.0002
437 HYPERTHYROIDISM 3 0.0002
438 FLUID OVERLOAD 3 0.0002
439 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
440 INFLAMMATORY BOWEL DISEASE 2 0.0002
441 CONSTIPATION 44 0.0002
442 INFLAMMATORY MARKER INCREASED 1 0.0002
443 ABDOMINAL TENDERNESS 1 0.0002
444 IMMUNODEFICIENCY 3 0.0002
445 INJECTION SITE INFLAMMATION 1 0.0002
446 APPLICATION SITE SWELLING 1 0.0002
447 HAEMORRHAGE INTRACRANIAL 3 0.0002
448 FLUID INTAKE REDUCED 1 0.0002
449 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
450 PERITONITIS BACTERIAL 2 0.0002
451 ECONOMIC PROBLEM 3 0.0002
452 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
453 SLUGGISHNESS 2 0.0002
454 CEREBRAL ISCHAEMIA 1 0.0002
455 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
456 DELUSION 3 0.0002
457 FAILURE TO THRIVE 1 0.0002
458 ACUTE MYELOID LEUKAEMIA 3 0.0002
459 MUCOSAL INFLAMMATION 5 0.0002
460 CATATONIA 1 0.0002
461 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
462 IRRITABLE BOWEL SYNDROME 4 0.0002
463 ANAL FISSURE 1 0.0002
464 HEREDITARY ANGIOEDEMA 2 0.0002
465 ABDOMINAL PAIN 43 0.0002
466 CHEILITIS 1 0.0002
467 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
468 METASTASES TO BONE 3 0.0002
469 MULTIPLE FRACTURES 3 0.0002
470 JAW DISORDER 1 0.0002
471 FAECALOMA 1 0.0002
472 ASTHENOPIA 1 0.0002
473 CHOKING SENSATION 1 0.0002
474 EXPIRED PRODUCT ADMINISTERED 6 0.0002
475 FOOT DEFORMITY 2 0.0002
476 FACE OEDEMA 3 0.0002
477 COLECTOMY 1 0.0002
478 MYOCARDIAL ISCHAEMIA 2 0.0002
479 GRANULOCYTOPENIA 1 0.0002
480 SCAB 2 0.0002
481 SCAR 3 0.0002
482 MICTURITION URGENCY 2 0.0002
483 HYPERTONIA 1 0.0002
484 MYOCARDITIS 2 0.0002
485 EXERCISE TOLERANCE DECREASED 1 0.0002
486 MOUTH SWELLING 1 0.0002
487 BLOOD URIC ACID INCREASED 1 0.0002
488 LOCAL SWELLING 3 0.0002
489 HYPOVOLAEMIA 1 0.0002
490 OSTEOPOROSIS 7 0.0002
491 ENERGY INCREASED 1 0.0002
492 BRADYKINESIA 1 0.0002
493 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
494 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 12 0.0002
495 GANGRENE 1 0.0002
496 APHASIA 5 0.0002
497 RENAL FAILURE ACUTE 7 0.0002
498 BURSITIS 2 0.0002
499 ADRENAL INSUFFICIENCY 2 0.0002
500 END STAGE RENAL DISEASE 3 0.0002
501 RESPIRATORY DEPRESSION 2 0.0002
502 ENCEPHALOPATHY 4 0.0002
503 CARDIOMEGALY 2 0.0002
504 LARYNGEAL OEDEMA 1 0.0002
505 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
506 CONJUNCTIVITIS 3 0.0002
507 GENERALISED OEDEMA 2 0.0002
508 PHARYNGITIS 2 0.0002
509 INFUSION SITE EXTRAVASATION 1 0.0002
510 URINARY TRACT INFECTION 27 0.0002
511 NEUROPATHY PERIPHERAL 15 0.0002
512 CYSTITIS 5 0.0002
513 PULMONARY FIBROSIS 3 0.0002
514 PRODUCT SUBSTITUTION ISSUE 9 0.0002
515 ENTERITIS 1 0.0002
516 ACUTE RESPIRATORY FAILURE 3 0.0002
517 HERPES SIMPLEX 1 0.0002
518 ANGINA UNSTABLE 1 0.0002
519 DEAFNESS 4 0.0002
520 DYSGRAPHIA 1 0.0002
521 ADVERSE REACTION 2 0.0002
522 MENINGITIS 1 0.0001
523 SWELLING 14 0.0001
524 CYTOKINE RELEASE SYNDROME 3 0.0001
525 BREAST MASS 1 0.0001
526 BONE MARROW FAILURE 3 0.0001
527 DISCOMFORT 9 0.0001
528 DRUG EXPOSURE DURING PREGNANCY 5 0.0001
529 CHRONIC KIDNEY DISEASE 11 0.0001
530 LYMPHOEDEMA 1 0.0001
531 INTERSTITIAL LUNG DISEASE 7 0.0001
532 INTENTIONAL DRUG MISUSE 3 0.0001
533 BLISTER 8 0.0001
534 DUODENAL ULCER 1 0.0001
535 OSTEOARTHRITIS 6 0.0001
536 SEASONAL ALLERGY 2 0.0001
537 DIVERTICULUM 1 0.0001
538 BRONCHOSPASM 2 0.0001
539 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
540 PRODUCT USE ISSUE 26 0.0001
541 SWELLING FACE 9 0.0001
542 DERMATITIS BULLOUS 1 0.0001
543 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
544 RESPIRATORY FAILURE 10 0.0001
545 GASTROENTERITIS 2 0.0001
546 MAJOR DEPRESSION 1 0.0001
547 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
548 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
549 RASH MACULO-PAPULAR 3 0.0001
550 EYE SWELLING 5 0.0001
551 PULMONARY MASS 2 0.0001
552 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
553 LIPASE INCREASED 1 0.0001
554 ATRIOVENTRICULAR BLOCK 1 0.0001
555 COGNITIVE DISORDER 6 0.0001
556 BONE DENSITY DECREASED 4 0.0001
557 GASTROINTESTINAL INFLAMMATION 1 0.0001
558 MULTIPLE ALLERGIES 1 0.0001
559 AFFECTIVE DISORDER 1 0.0001
560 PRODUCT USE COMPLAINT 2 0.0001
561 FURUNCLE 1 0.0001
562 BLOOD ALBUMIN DECREASED 1 0.0001
563 ULCER 2 0.0001
564 OBESITY 2 0.0001
565 SCIATICA 2 0.0001
566 PANCYTOPENIA 7 0.0001
567 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 6 0.0001
568 MIOSIS 1 0.0001
569 DYSKINESIA 5 0.0001
570 DECUBITUS ULCER 1 0.0001
571 LUNG DISORDER 6 0.0001
572 HICCUPS 1 0.0001
573 HAIR DISORDER 1 0.0001
574 DRY EYE 6 0.0001
575 PNEUMONIA ASPIRATION 3 0.0001
576 POLLAKIURIA 5 0.0001
577 HAEMODIALYSIS 1 0.0001
578 CELLULITIS 6 0.0001
579 INFUSION SITE ERYTHEMA 1 0.0001
580 CARDIAC OPERATION 1 0.0001
581 SKIN ULCER 3 0.0001
582 MULTI-ORGAN FAILURE 2 0.0001
583 HYSTERECTOMY 1 0.0001
584 EOSINOPHILIA 2 0.0001
585 BLOOD CALCIUM INCREASED 1 0.0001
586 GRIP STRENGTH DECREASED 1 0.0001
587 LYMPHOCYTE COUNT DECREASED 2 0.0001
588 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
589 DRUG INEFFECTIVE 148 0.0001
590 MATERNAL EXPOSURE DURING PREGNANCY 10 0.0001
591 HAEMOLYTIC ANAEMIA 1 0.0001
592 HAEMARTHROSIS 1 0.0001
593 GASTROINTESTINAL INFECTION 1 0.0001
594 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
595 HEAVY MENSTRUAL BLEEDING 1 0.0001
596 LUPUS-LIKE SYNDROME 1 0.0001
597 PELVIC PAIN 2 0.0001
598 SKIN IRRITATION 5 0.0001
599 PRODUCT USE IN UNAPPROVED INDICATION 27 0.0001
600 INCREASED TENDENCY TO BRUISE 1 0.0001
601 HYPOKALAEMIA 5 0.0001
602 GRAND MAL CONVULSION 1 0.0001
603 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
604 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
605 HAEMOPTYSIS 3 0.0001
606 HEPATIC STEATOSIS 2 0.0001
607 BACTERIAL INFECTION 2 0.0001
608 APPENDICITIS 1 0.0001
609 ERYTHEMA 22 0.0001
610 DEFORMITY 1 0.0001
611 OEDEMA PERIPHERAL 13 0.0001
612 LACERATION 1 0.0001
613 ABORTION INDUCED 1 0.0001
614 FOOT FRACTURE 2 0.0001
615 DYSPHAGIA 10 0.0001
616 COMA 5 0.0001
617 DIABETES MELLITUS 8 0.0001
618 RASH ERYTHEMATOUS 5 0.0001
619 HERPES ZOSTER 6 0.0001
620 DRUG PRESCRIBING ERROR 2 0.0001
621 DIZZINESS POSTURAL 1 0.0001
622 HEPATOMEGALY 1 0.0001
623 KNEE OPERATION 1 0.0001
624 URINARY INCONTINENCE 3 0.0001
625 HOSPICE CARE 1 0.0001
626 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
627 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
628 RENAL INJURY 3 0.0001
629 SINUS DISORDER 2 0.0001
630 HAEMATOCRIT DECREASED 2 0.0001
631 INABILITY TO AFFORD MEDICATION 1 0.0001
632 UPPER LIMB FRACTURE 2 0.0001
633 BRAIN INJURY 1 0.0001
634 HYPOTHERMIA 1 0.0001
635 EYELID PTOSIS 1 0.0001
636 NEUTROPHIL COUNT DECREASED 4 0.0001
637 MOTOR DYSFUNCTION 1 0.0001
638 BODY TEMPERATURE INCREASED 2 0.0001
639 ACUTE KIDNEY INJURY 15 0.0001
640 DRUG ADMINISTRATION ERROR 3 0.0001
641 HELICOBACTER INFECTION 1 0.0001
642 RIB FRACTURE 2 0.0001
643 EXPOSURE DURING PREGNANCY 6 0.0001
644 ROAD TRAFFIC ACCIDENT 4 0.0001
645 SPEECH DISORDER 5 0.0001
646 SEIZURE 11 0.0001
647 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
648 HALLUCINATION, VISUAL 2 0.0001
649 JOINT DISLOCATION 1 0.0001
650 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
651 WEIGHT DECREASED 26 0.0001
652 CONFUSIONAL STATE 15 0.0001
653 BALANCE DISORDER 8 0.0001
654 BIPOLAR DISORDER 1 0.0001
655 MENTAL DISORDER 4 0.0001
656 ASPIRATION 1 0.0001
657 BLOOD GLUCOSE FLUCTUATION 1 0.0001
658 EYE DISORDER 3 0.0001
659 MELAENA 2 0.0001
660 ANAPHYLACTIC REACTION 5 0.0001
661 FEBRILE NEUTROPENIA 6 0.0001
662 RENAL FAILURE 12 0.0001
663 BLOOD PRESSURE DECREASED 6 0.0001
664 SYNCOPE 9 0.0001
665 PULMONARY OEDEMA 4 0.0001
666 ANAEMIA 17 0.0001
667 INTESTINAL PERFORATION 1 0.0001
668 CHROMATURIA 2 0.0001
669 ASTHMA 10 0.0001
670 HEPATIC ENZYME INCREASED 6 0.0001
671 IMPAIRED DRIVING ABILITY 1 0.0001
672 ANXIETY 25 0.0001
673 PRODUCT AVAILABILITY ISSUE 2 0.0001
674 HAEMOGLOBIN DECREASED 9 0.0001
675 CARDIAC FAILURE 7 0.0001
676 SKIN DISCOLOURATION 4 0.0001
677 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
678 METASTASES TO LUNG 1 0.0001
679 PERICARDIAL EFFUSION 2 0.0001
680 DELIRIUM 3 0.0001
681 EYELID OEDEMA 1 0.0001
682 PRURITUS 33 0.0001
683 RENAL DISORDER 4 0.0001
684 CARDIAC DISORDER 8 0.0001
685 HYPOXIA 3 0.0001
686 OCULAR HYPERAEMIA 4 0.0001
687 ACCIDENT 1 0.0001
688 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
689 RENAL IMPAIRMENT 7 0.0001
690 DIABETIC KETOACIDOSIS 2 0.0001
691 CONTUSION 8 0.0001
692 CRYING 3 0.0001
693 HYPOGLYCAEMIA 4 0.0001
694 C-REACTIVE PROTEIN INCREASED 3 0.0001
695 STOMATITIS 5 0.0001
696 PRESYNCOPE 2 0.0001
697 ATRIAL FIBRILLATION 8 0.0001
698 RESTLESSNESS 3 0.0001
699 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
700 OSTEONECROSIS OF JAW 2 0.0001
701 ILEUS 1 0.0001
702 HEPATIC FUNCTION ABNORMAL 3 0.0001
703 CARDIOVASCULAR DISORDER 2 0.0001
704 HYPOPHAGIA 2 0.0001
705 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
706 ERECTILE DYSFUNCTION 2 0.0001
707 INFUSION SITE PAIN 1 0.0001
708 URTICARIA 13 0.0001
709 ANOREXIA 1 0.0001
710 HIATUS HERNIA 1 0.0001
711 INJECTION SITE INDURATION 1 0.0001
712 RESPIRATORY TRACT INFECTION 2 0.0001
713 SEDATION 2 0.0001
714 GASTRITIS 2 0.0001
715 IMMUNE SYSTEM DISORDER 1 0.0001
716 ANKYLOSING SPONDYLITIS 1 0.0001
717 DYSMENORRHOEA 1 0.0001
718 EAR INFECTION 2 0.0001
719 EYE HAEMORRHAGE 1 0.0001
720 ABORTION SPONTANEOUS 3 0.0001
721 JOINT RANGE OF MOTION DECREASED 1 0.0001
722 EMOTIONAL DISTRESS 9 0.0001
723 DIZZINESS 37 0.0001
724 PULMONARY EMBOLISM 7 0.0001
725 PNEUMONITIS 2 0.0001
726 DRUG TOXICITY 1 0.0001
727 RASH 32 0.0001
728 GINGIVAL BLEEDING 1 0.0001
729 CORONARY ARTERY OCCLUSION 1 0.0001
730 MENTAL STATUS CHANGES 2 0.0001
731 COORDINATION ABNORMAL 1 0.0001
732 DEMENTIA 2 0.0001
733 WOUND 2 0.0001
734 OXYGEN SATURATION DECREASED 4 0.0001
735 BLOOD TEST ABNORMAL 1 0.0001
736 LYMPHOPENIA 1 0.0001
737 FLATULENCE 4 0.0001
738 DIALYSIS 1 0.0001
739 RED BLOOD CELL COUNT DECREASED 2 0.0001
740 RECTAL HAEMORRHAGE 3 0.0001
741 SKIN BURNING SENSATION 5 0.0001
742 CARDIOGENIC SHOCK 1 0.0001
743 DEVICE DISLOCATION 3 0.0001
744 SEPTIC SHOCK 3 0.0001
745 BACK PAIN 16 0.0001
746 APATHY 1 0.0001
747 OFF LABEL USE 60 0.0001
748 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
749 LIVER DISORDER 3 0.0001
750 TACHYCARDIA 6 0.0001
751 DEHYDRATION 9 0.0001
752 RESPIRATORY DISORDER 2 0.0001
753 EPISTAXIS 5 0.0001
754 BONE LOSS 1 0.0001
755 HEPATIC FAILURE 2 0.0001
756 LACRIMATION INCREASED 2 0.0001
757 PLEURAL EFFUSION 4 0.0001
758 VERTIGO 4 0.0001
759 VISION BLURRED 9 0.0001
760 NEPHROLITHIASIS 3 0.0001
761 INSURANCE ISSUE 1 0.0001
762 EJECTION FRACTION DECREASED 1 0.0001
763 SWOLLEN TONGUE 2 0.0001
764 BRAIN FOG 1 0.0001
765 CYANOSIS 1 0.0001
766 ARTHRITIS 5 0.0001
767 PAIN 39 0.0001
768 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
769 HALLUCINATION, AUDITORY 1 0.0001
770 PRODUCTIVE COUGH 3 0.0001
771 ABSCESS 1 0.0001
772 THROMBOCYTOPENIA 7 0.0001
773 LOSS OF CONSCIOUSNESS 8 0.0001
774 MOVEMENT DISORDER 2 0.0001
775 INFECTION 9 0.0001
776 DYSPNOEA 35 0.0001
777 DRY MOUTH 5 0.0001
778 BLOOD POTASSIUM INCREASED 1 0.0001
779 DEPRESSION 14 0.0001
780 HYPERTENSION 13 0.0001
781 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 11 0.0001
782 IMPAIRED HEALING 2 0.0001
783 MANIA 1 0.0001
784 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
785 DRUG LEVEL INCREASED 1 0.0001
786 OVERDOSE 13 0.0001
787 LIP SWELLING 2 0.0001
788 SKIN DISORDER 2 0.0001
789 MUSCLE SPASMS 11 0.0001
790 URINARY RETENTION 2 0.0001
791 DRY SKIN 8 0.0001
792 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
793 SKIN EXFOLIATION 5 0.0001
794 PNEUMONIA 19 0.0001
795 METRORRHAGIA 1 0.0001
796 CHEST DISCOMFORT 6 0.0001
797 SINUSITIS 6 0.0001
798 FEELING ABNORMAL 14 0.0001
799 PYREXIA 20 0.0001
800 NIGHTMARE 2 0.0001
801 DEVICE DEFECTIVE 1 0.0001
802 GAIT DISTURBANCE 11 0.0001
803 HAEMORRHAGE 6 0.0001
804 HYPERKALAEMIA 2 0.0001
805 COVID-19 10 0.0001
806 HEART RATE DECREASED 2 0.0001
807 INJURY 4 0.0001
808 SLEEP DISORDER 4 0.0001
809 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
810 HEAD DISCOMFORT 1 0.0001
811 DRUG ERUPTION 1 0.0001
812 GALLBLADDER DISORDER 1 0.0001
813 CEREBRAL HAEMORRHAGE 2 0.0001
814 ADVERSE DRUG REACTION 5 0.0001
815 DISTURBANCE IN ATTENTION 3 0.0001
816 GASTROENTERITIS VIRAL 1 0.0001
817 ACCIDENTAL OVERDOSE 2 0.0001
818 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
819 SOMNOLENCE 11 0.0001
820 AGITATION 4 0.0001
821 PAIN IN EXTREMITY 16 0.0001
822 INFLUENZA 6 0.0001
823 HYPONATRAEMIA 3 0.0001
824 BLOOD SODIUM DECREASED 1 0.0001
825 ARTHRALGIA 22 0.0001
826 UNEVALUABLE EVENT 4 0.0001
827 HYPOCALCAEMIA 1 0.0001
828 MUSCULAR WEAKNESS 6 0.0001
829 COLITIS 2 0.0001
830 GASTRIC ULCER 1 0.0001
831 CONVULSION 3 0.0001
832 PERIPHERAL SWELLING 8 0.0001
833 GLAUCOMA 1 0.0001
834 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
835 DRUG INTOLERANCE 5 0.0001
836 HERNIA 1 0.0001
837 DYSTONIA 1 0.0001
838 HAEMORRHOIDS 1 0.0001
839 CHILLS 6 0.0001
840 SURGERY 3 0.0001
841 KIDNEY INFECTION 1 0.0001
842 ALOPECIA 10 0.0001
843 HEART RATE INCREASED 5 0.0001
844 BLOOD PRESSURE ABNORMAL 1 0.0001
845 CARDIAC FAILURE CONGESTIVE 4 0.0000
846 ILL-DEFINED DISORDER 3 0.0000
847 FEEDING DISORDER 1 0.0000
848 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
849 INJECTION SITE WARMTH 1 0.0000
850 ILLNESS 5 0.0000
851 TREATMENT FAILURE 4 0.0000
852 MALAISE 21 0.0000
853 EATING DISORDER 1 0.0000
854 PLATELET COUNT DECREASED 5 0.0000
855 IMPAIRED WORK ABILITY 1 0.0000
856 DIARRHOEA 30 0.0000
857 HYPOACUSIS 2 0.0000
858 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
859 AMNESIA 3 0.0000
860 BLOOD PRESSURE INCREASED 7 0.0000
861 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
862 HOSPITALISATION 7 0.0000
863 INFUSION RELATED REACTION 3 0.0000
864 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
865 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 9 0.0000
866 HEART RATE IRREGULAR 1 0.0000
867 RHEUMATOID ARTHRITIS 5 0.0000
868 SUICIDAL IDEATION 4 0.0000
869 MEMORY IMPAIRMENT 6 0.0000
870 TINNITUS 2 0.0000
871 ADVERSE EVENT 4 0.0000
872 CHEST PAIN 8 0.0000
873 ARRHYTHMIA 2 0.0000
874 TREMOR 7 0.0000
875 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
876 MIGRAINE 4 0.0000
877 BLOOD PRESSURE FLUCTUATION 1 0.0000
878 LOCALISED INFECTION 1 0.0000
879 CEREBROVASCULAR ACCIDENT 7 0.0000
880 INSOMNIA 11 0.0000
881 MENTAL IMPAIRMENT 1 0.0000
882 CEREBRAL INFARCTION 1 0.0000
883 PRODUCT DOSE OMISSION ISSUE 12 0.0000
884 ABASIA 1 0.0000
885 LEUKOPENIA 2 0.0000
886 HALLUCINATION 3 0.0000
887 FLUID RETENTION 2 0.0000
888 COUGH 11 0.0000
889 HEPATITIS 1 0.0000
890 DRUG RESISTANCE 1 0.0000
891 ABDOMINAL PAIN UPPER 8 0.0000
892 ANAPHYLACTIC SHOCK 1 0.0000
893 ABDOMINAL DISTENSION 4 0.0000
894 ECZEMA 2 0.0000
895 BREAST CANCER FEMALE 1 0.0000
896 JAUNDICE 1 0.0000
897 BLOOD BILIRUBIN INCREASED 1 0.0000
898 RASH PRURITIC 2 0.0000
899 OEDEMA 2 0.0000
900 NEUTROPENIA 5 0.0000
901 TREATMENT NONCOMPLIANCE 2 0.0000
902 ABNORMAL DREAMS 1 0.0000
903 ARTHROPATHY 2 0.0000
904 MEDICATION ERROR 2 0.0000
905 FEELING COLD 1 0.0000
906 ABDOMINAL DISCOMFORT 6 0.0000
907 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
908 INTENTIONAL DOSE OMISSION 1 0.0000
909 ANGINA PECTORIS 1 0.0000
910 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
911 LIVER FUNCTION TEST ABNORMAL 1 0.0000
912 DYSSTASIA 1 0.0000
913 PALPITATIONS 4 0.0000
914 BONE PAIN 2 0.0000
915 LABORATORY TEST ABNORMAL 1 0.0000
916 CATARACT 2 0.0000
917 GASTROINTESTINAL DISORDER 3 0.0000
918 HYPOAESTHESIA 5 0.0000
919 BLOOD POTASSIUM DECREASED 1 0.0000
920 NO ADVERSE EVENT 6 0.0000
921 FALL 11 0.0000
922 FEELING HOT 2 0.0000
923 INJECTION SITE RASH 1 0.0000
924 GYNAECOMASTIA 1 0.0000
925 FEMUR FRACTURE 1 0.0000
926 VISUAL IMPAIRMENT 4 0.0000
927 ASTHENIA 12 0.0000
928 HEADACHE 20 0.0000
929 WEIGHT INCREASED 7 0.0000
930 DECREASED APPETITE 7 0.0000
931 NEOPLASM MALIGNANT 2 0.0000
932 GAIT INABILITY 1 0.0000
933 VOMITING 14 0.0000
934 EYE PRURITUS 1 0.0000
935 GASTRIC DISORDER 1 0.0000
936 NAUSEA 23 0.0000
937 LYMPHADENOPATHY 1 0.0000
938 THERAPY INTERRUPTED 2 0.0000
939 HYPERGLYCAEMIA 1 0.0000
940 INJECTION SITE MASS 1 0.0000
941 DYSGEUSIA 2 0.0000
942 DYSARTHRIA 1 0.0000
943 INJECTION SITE SWELLING 2 0.0000
944 DEATH 22 0.0000
945 ABNORMAL BEHAVIOUR 1 0.0000
946 DISORIENTATION 1 0.0000
947 HYPOTENSION 5 0.0000
948 THROMBOSIS 2 0.0000
949 FATIGUE 19 0.0000
950 LUNG NEOPLASM MALIGNANT 1 0.0000
951 INFLUENZA LIKE ILLNESS 2 0.0000
952 INJECTION SITE ERYTHEMA 3 0.0000
953 COMPLETED SUICIDE 2 0.0000
954 CARDIO-RESPIRATORY ARREST 1 0.0000
955 MYALGIA 4 0.0000
956 DEVICE LEAKAGE 1 0.0000
957 INTENTIONAL PRODUCT MISUSE 2 0.0000
958 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
959 ANGIOEDEMA 1 0.0000
960 COLITIS ULCERATIVE 1 0.0000
961 DEVICE ISSUE 2 0.0000
962 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
963 NASOPHARYNGITIS 4 0.0000
964 OROPHARYNGEAL PAIN 2 0.0000
965 BREAST CANCER 2 0.0000
966 BLOOD GLUCOSE DECREASED 1 0.0000
967 DYSPEPSIA 2 0.0000
968 AGGRESSION 1 0.0000
969 FLUSHING 2 0.0000
970 INFLAMMATION 1 0.0000
971 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
972 DERMATITIS ATOPIC 1 0.0000
973 DRUG DEPENDENCE 3 0.0000
974 DRUG EFFECT DECREASED 1 0.0000
975 DRUG DOSE OMISSION 3 0.0000
976 HAEMATOCHEZIA 1 0.0000
977 TOXICITY TO VARIOUS AGENTS 3 0.0000
978 EYE PAIN 1 0.0000
979 INCORRECT DOSE ADMINISTERED 4 0.0000
980 LETHARGY 1 0.0000
981 EYE IRRITATION 1 0.0000
982 DISEASE PROGRESSION 2 0.0000
983 IRRITABILITY 1 0.0000
984 JOINT SWELLING 2 0.0000
985 INJECTION SITE PAIN 5 0.0000
986 DEEP VEIN THROMBOSIS 1 0.0000
987 PRODUCT QUALITY ISSUE 2 0.0000
988 MOBILITY DECREASED 1 0.0000
989 BRONCHITIS 1 0.0000
990 HOT FLUSH 1 0.0000
991 ACNE 1 0.0000
992 CARDIAC ARREST 1 0.0000
993 HYPERHIDROSIS 1 0.0000
994 BLOOD GLUCOSE INCREASED 1 0.0000